Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy
Biomolecules · 2025
DOI: 10.3390/biom15121739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Shahaf Peleg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and the Institute of Nanotechnology and Advanced Materials, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002…. Hauptthemen laut MEDLINE: Cation Transport Proteins, Copper, Neoplasms, Neurodegenerative Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, ISF-Hamavrie.
Abstract (Originalsprache)
Copper transporter 1 (CTR1) is the primary high affinity importer for Cu(I) in eukaryotic cells. CTR1 plays an essential role in maintaining copper homeostasis which is crucial for diverse biological processes. Since its discovery in 1997, research on human CTR1 (hCTR1) has progressed from foundational biochemical characterization to detailed structural and functional elucidation, expanding our understanding of its involvement in human diseases. Here we summarize the current understanding of hCTR1, including its structural features, copper-binding motifs, regulation, trafficking pathways, and roles in disease. We also highlight emerging evidence implicating hCTR1 in cancer, neurodegenerative disorders, and inherited copper metabolism syndromes, emphasizing its potential as a therapeutic target and drug delivery facilitator. Finally, we discuss recent studies and outline future directions, aimed at fully harnessing the biomedical potential of hCTR1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and the Institute of Nanotechnology and Advanced Materials, Faculty of Exact Sciences, Bar Ilan University, Ramat-Gan 5290002, Israel.
ORCID-Profile: Lukas Hofmann, Sharon Ruthstein
Förderung
- Israel Science Foundation
- ISF-Hamavrie
Zitieren
APA
Peleg, S., Hofmann, L., & Ruthstein, S. (2025). Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy. Biomolecules. https://doi.org/10.3390/biom15121739
Vancouver
Peleg S, Hofmann L, Ruthstein S. Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy. Biomolecules. 2025. doi:10.3390/biom15121739
BibTeX
@article{Peleg2025,
author = {Peleg, Shahaf and Hofmann, Lukas and Ruthstein, Sharon},
title = {Human CTR1 Through the Ages: Milestones and Emerging Roles in Disease and Therapy},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15121739}
}
EUVIMED